1. Can novel methods replace the gold standard chimerism method after allogeneic hematopoietic stem cell transplantation?

   • Figen Abatay Sel
   • Fatma Savran Oğuz

   Review Article 06 October 2023 Pages: 1035 - 1047

   

2. TP53-mutated acute myeloid leukemia and myelodysplastic syndrome: biology, treatment challenges, and upcoming approaches

   • Mariana Pinto Pereira
   • Elizabeth Herrity
   • Dennis D.H Kim

   Review Article 28 September 2023 Pages: 1049 - 1067

   

3. BCMA-targeting chimeric antigen receptor T cell therapy for relapsed and/or refractory multiple myeloma

   • Jiamin Fang
   • Fuling Zhou

   Review Article 13 September 2023 Pages: 1069 - 1083

   

4. The role of TMPRSS6 gene polymorphism in iron resistance iron deficiency anaemia (IRIDA): a systematic review

   • Antika Sharma
   • Anil Kumar
   • Lekha Saha

   Review Article 11 December 2023 Pages: 1085 - 1102

   

5. Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification

   • Synne D. Rørvik
   • Synne Torkildsen
   • Tor Henrik Anderson Tvedt

   Review Article Open access 06 March 2024 Pages: 1103 - 1119

6. Radiation hazards of the Ukraine nuclear power plants: how can international blood and marrow stem cell transplant societies help?

   • Shahrukh K. Hashmi
   • Ray C. Powles
   • Hildegard Greinix

   Review Article 06 June 2023 Pages: 1121 - 1129

   

7. Paraneoplastic syndromes associated with classic Hodgkin lymphoma, a systematic literature review

   • Riad El Fakih
   • Yazeed S. Bajuaifer
   • Mahmoud Aljurf

   Review Article 10 July 2023 Pages: 1131 - 1137

   

8. Healthcare resource utilization of patients with warm autoimmune hemolytic anemia initiating first line therapy of oral corticosteroids with or without rituximab

   • Irina Murakhovskaya
   • Concetta Crivera
   • Tarek Ebrahim

   Original Article 01 February 2024 Pages: 1139 - 1147

   

9. Bone marrow biopsy in geriatric patients above the age of 85 years: invaluable or unnecessary? A retrospective analysis

   • Kailun David Zhang
   • Edgar Jost
   • Susanne Isfort

   Original Article Open access 10 February 2024 Pages: 1149 - 1158

   

10. Association of a decreased platelet count with poor survival in patients with adult secondary hemophagocytic lymphohistiocytosis

    • Wanying Cheng
    • Ji Xu
    • Guangli Yin

    Original Article 20 February 2024 Pages: 1159 - 1166

    

11. Comparative transcriptomic analysis of circulating endothelial cells in sickle cell stroke

    • Júlia Nicoliello Pereira de Castro
    • Sueli Matilde da Silva Costa
    • Mônica Barbosa de Melo

    Original Article 22 February 2024 Pages: 1167 - 1179

    

12. Identification of a novel fusion gene, RARA::ANKRD34C, in acute promyelocytic leukemia

    • Yue Chen
    • Mengge Pan
    • Peipei Xu

    Original Article 31 January 2024 Pages: 1181 - 1185

    

13. Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation

    • Josephine Lucero
    • Muhned Alhumaid
    • Dennis D. H. Kim

    Original Article 30 January 2024 Pages: 1187 - 1196

    

14. Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study

    • Lei Zhao
    • Jinjun Yang
    • Yu Wu

    Research 08 February 2024 Pages: 1197 - 1209

    

15. Myelodysplasia-related gene mutations are associated with favorable prognosis in patients with TP53-mutant acute myeloid leukemia

    • Yi Chen
    • Jing Zheng
    • Yong Wu

    Research 27 February 2024 Pages: 1211 - 1220

    

16. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms

    • Alexander Streuer
    • Johann-Christoph Jann
    • Daniel Nowak

    Research Open access 27 February 2024 Pages: 1221 - 1233

    

17. Clinical characteristics and treatment outcomes of Asian patients with T-cell large granular lymphocytic Leukemia: a single-center analysis of 67 cases

    • Taekeun Park
    • Ja Min Byun
    • Inho Kim

    Original Article Open access 08 December 2023 Pages: 1235 - 1240

    

18. Investigation of fatty acid metabolism in chronic lymphocytic leukemia to guide clinical outcome and therapy

    • Bihui Pan
    • Zhangdi Xu
    • Jiazhu Wu

    Original Article 27 December 2023 Pages: 1241 - 1254

    

19. Castleman disease- demographics, associations, and outcomes: an analysis of adult 791 cases

    • Rushin Patel
    • Darshil Patel
    • Zalak Patel

    Original Article 02 December 2023 Pages: 1255 - 1260

20. Prognostic significance of serum monoclonal proteins based on immunofixation electrophoresis in B-cell non-Hodgkin lymphoma

    • Yuyang Gao
    • Xiaoyan Feng
    • Mingzhi Zhang

    Original Article 20 December 2023 Pages: 1261 - 1271

    

21. Recent trends in incidence, survival and treatment of multiple myeloma in Finland – a nationwide cohort study

    • Jarno Ruotsalainen
    • Leena Lehmus
    • Maarit Jaana Korhonen

    Original Article Open access 12 December 2023 Pages: 1273 - 1284

    

22. Elevated serum IL-6 and total IgEAb are associated with poor survival in natural killer/T-cell lymphoma

    • Yun Hui
    • Yingjun Gao
    • Hong Sang

    Original Article 14 December 2023 Pages: 1285 - 1292

    

23. Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells

    • Wei Hu
    • Jingqi Sun
    • Jiliang Xia

    Original Article 27 December 2023 Pages: 1293 - 1303

    

24. Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)

    • Lihui Shi
    • Wenqiang Yan
    • Gang An

    Original Article 05 December 2023 Pages: 1305 - 1315

    

25. Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patients

    • Ana Cristina Olivas-Bejarano
    • Laura Arcelia Montiel-Cervantes
    • Jorge Vela-Ojeda

    Original Article 13 December 2023 Pages: 1317 - 1325

    

26. Dismal prognosis of Pneumocystis jirovecii pneumonia in patients with multiple myeloma

    • C Riedhammer
    • J Düll
    • L Rasche

    Original Article Open access 20 December 2023 Pages: 1327 - 1332

27. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study

    • Shuang Fan
    • Xiaodong Mo
    • Xiaojun Huang

    Original Article 21 February 2024 Pages: 1333 - 1344

    

28. Decitabine-containing conditioning improved outcomes for children with higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation

    • Yuanyuan Ren
    • Fang Liu
    • Ye Guo

    Original Article 06 February 2024 Pages: 1345 - 1351

    

29. Outcomes of haploidentical peripheral blood stem cell transplantation following myeloablative conditioning using two types of rabbit ATG: a propensity score-matched analysis

    • Zhuoyue Shi
    • Fei Gao
    • Yanmin Zhao

    Original Article 02 March 2024 Pages: 1353 - 1362

    

30. Pretransplantation predictors of survival in nonremission acute myeloid leukemia treated with haploidentical transplantation using steroid-based GVHD prophylaxis

    • Masahiro Teramoto
    • Hiroya Tamaki
    • Satoshi Yoshihara

    Original Article 23 February 2024 Pages: 1363 - 1372

    

31. Transfusion of blood components in pediatric age groups: an evidence-based clinical practice guideline adapted for the use in Egypt using ‘Adapted ADAPTE’

    • Galila Mokhtar
    • Amira Adly
    • Egyptian Pediatric Clinical Practice Guidelines Committee (EPG)

    Original Article Open access 22 February 2024 Pages: 1373 - 1388

32. Comparing transfusion reactions between pre-storage and post-storage leukoreduced apheresis platelets: an analysis using propensity score matching

    • Sheng-Hsuan Chien
    • Hsin-Yi Huang
    • Chun-Yu Liu

    Research Open access 23 February 2024 Pages: 1389 - 1396

    

33. Successful treatment of a B/T MPAL patient by chemo-free treatment with venetoclax, azacitidine, and blinatumomab

    • Shaoyu Liu
    • Qingya Cui
    • Xiaowen Tang

    Case Report Open access 17 February 2024 Pages: 1397 - 1402

    

34. Isolated massive pleural effusion as a manifestation of chronic graft versus host disease successfully treated with corticosteroid

    • Yasutaka Masuda
    • Sho Yamazaki
    • Mineo Kurokawa

    Case Report Open access 29 January 2024 Pages: 1403 - 1407

    

35. A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration

    • Takayuki Goto
    • Nobuhiko Nakamura
    • Masahito Shimizu

    Letter to the Editor 20 February 2024 Pages: 1409 - 1410

    

36. Negative effect of paraskeletal plasmacytoma on survival of patients with transplant-ineligible newly diagnosed multiple myeloma

    • Junzhe Wang
    • Xiaoning Song
    • Lixia Sun

    Letter to the Editor 16 January 2024 Pages: 1411 - 1414

    

37. Intramedullary leukocytoclastic vasculitis and neutrophil extracellular trap (NET) formation in POEMS syndrome

    • Wiebke Aderhold
    • Benjamin Lenz
    • Ines Gütgemann

    Letter to the Editor Open access 04 March 2024 Pages: 1415 - 1417

    

38. Effectiveness and safety of blinatumomab for pediatric B cell acute lymphoblastic leukemia with Loeffler’s endocarditis

    • Xiaolan Li
    • Jingchong Zhou
    • Wenyu Yang

    Letter to the Editor 17 February 2024 Pages: 1419 - 1420

    

39. Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement

    • Giovanni Martino
    • Gaetano Cimino
    • Maria Paola Martelli

    Correction 27 December 2023 Pages: 1421 - 1421